Aebi, S

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 22.

Journal Article

Burmeister, H; Aebi, S; Studer, C; Fey, M.F.; Gautschi, O (2012). Adherence to ESMO clinial recommendations for prophylaxis of chemotherapy-induced nausea and vomiting. Supportive care in cancer, 20(1), pp. 141-7. Berlin: Springer 10.1007/s00520-010-1079-3

Aebi, S; Sun, Z; Braun, D; Price, K N; Castiglione-Gertsch, M; Rabaglio, M; Gelber, R D; Crivellari, D; Lindtner, J; Snyder, R; Karlsson, P; Simoncini, E; Gusterson, B A; Viale, G; Regan, M M; Coates, A S; Goldhirsch, A (2011). Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX. Annals of oncology, 22(9), pp. 1981-7. Oxford: Oxford University Press 10.1093/annonc/mdq754

Moor, A E; Guevara, C; Altermatt, H J; Warth, R; Jaggi, R; Aebi, S (2011). PRO_10--a new tissue-based prognostic multigene marker in patients with early estrogen receptor-positive breast cancer. Pathobiology, 78(3), pp. 140-8. Basel: Karger 10.1159/000323809

Zbinden, S; Bühlmann, M; Aebi, S; Suter, T (2010). Kardiovaskuläre Nebenwirkungen der modernen, medikamentösen Krebstherapie. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, pp. 143-147. Basel: EMH Editores Medicorum Helveticorum

Eicher, M; Aebi, S; Biedermann, M; Günthert, A; Keller, T; Mueller, M; Zeyen, B (2010). Breast Care Nurse - Rollen, Kompetenzen und Funktionen. Newsletter der Deutschen Gesellschaft für Senologie, der Österreichischen Gesellschaft für Senologie und der Schweizerischen Gesellschaft für Senologie, p. 2. Stuttgart: Thieme

Imboden, S; Burger, H; Aebi, S; Mohr, S; Mueller, MD (2010). Der unklare Adenexbefund. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 10(42), pp. 737-738. Basel: EMH Editores Medicorum Helveticorum

Johann, S; Santi, A; Günthert, A; Lössl, K; Aebi, S; Mueller, MD (2010). Das Endometriumkarzinom: Diagnostik, Therapie und Nachsorge. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 10(7), pp. 129-33. Basel: EMH Editores Medicorum Helveticorum

Colleoni, M; Sun, Z; Martinelli, G; Basser, R L; Coates, A S; Gelber, R D; Green, M D; Peccatori, F; Cinieri, S; Aebi, S; Viale, G; Price, K N; Goldhirsch, A (2009). The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up. Annals of oncology, 20(8), pp. 1344-51. Oxford: Oxford University Press 10.1093/annonc/mdp024

Amstutz, U; Farese, S; Aebi, S; Largiadèr, CR (2009). Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: A haplotype assessment. Pharmacogenomics, 10(6), pp. 931-944. London: Future Medicine 10.2217/PGS.09.28

Bartholomeyczik, S; Schnell, M; Aebi, S (2008). [Effectiveness of specialized nursing for patients with breast cancer and other gynecologic cancers: a prospective, longitudinal, two-arm pilot study in Switzerland]. Pflege - die wissenschaftliche Zeitschrift für Pflegeberufe, 21(5), pp. 353-4. Bern: H. Huber 10.1024/1012-5302.21.5.353

Aebi, S; Loibl, S (2008). Breast cancer during pregnancy: medical therapy and prognosis. Recent results in cancer research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, 178, pp. 45-55. Berlin: Springer

Bernhard, J; Zahrieh, D; Zhang, J J; Martinelli, G; Basser, R; Hürny, C; Forbes, J F; Aebi, S; Yeo, W; Thürlimann, B; Green, M D; Colleoni, M; Gelber, R D; Castiglione-Gertsch, M; Price, K N; Goldhirsch, A; Coates, A S (2008). Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. British journal of cancer, 98(1), pp. 25-33. Basingstoke: Nature Publishing Group 10.1038/sj.bjc.6604092

Aebi, S; Castiglione, M (2008). Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology, 19 Suppl 2, ii14-6. Oxford: Oxford University Press 10.1093/annonc/mdn073

Harter, P; Aebi, S; Hilpert, F; du Bois, A (2008). Primär- und Rezidivtherapie des Ovarialkarzinoms. Onkologe, 1007(10), s00761-008-1473-3. Heidelberg: Springer-Medizin-Verlag

Eicher, M; Aebi, S (2008). Breast Care Nurses: Erstes Deutschsprachiges Lehrbuch erschienen. Schweizer Krebsbulletin / Bulletin suisse du cancer(4), p. 297. Bellinzona: Istituto oncologico della Svizzera Italiana

Bernhard, J; Zahrieh, D; Castiglione-Gertsch, M; Hürny, C; Gelber, RD; Forbes, JF; Murray, E; Collins, J; Aebi, S; Thürlimann, B; Price, KN; Goldhirsch, A; Coates, AS; International, Breast Cancer Study Group Trial VIII (2007). Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII. Journal of clinical oncology, 25(3), pp. 263-70. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.04.5393

Keshaviah, A; Dellapasqua, S; Rotmensz, N; Lindtner, J; Crivellari, D; Collins, J; Colleoni, M; Thürlimann, B; Mendiola, C; Aebi, S; Price, K N; Pagani, O; Simoncini, E; Castiglione Gertsch, M; Gelber, R D; Coates, A S; Goldhirsch, A (2007). CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials. Annals of oncology, 18(4), pp. 701-8. Oxford: Oxford University Press 10.1093/annonc/mdl492

Aebi, S; Castiglione, M (2006). The enigma of young age. Annals of oncology, 17(10), pp. 1475-7. Oxford: Oxford University Press 10.1093/annonc/mdl330

Colleoni, M; Gelber, S; Goldhirsch, A; Aebi, S; Castiglione-Gertsch, M; Price, KN; Coates, AS; Gelber, RD; International, Breast Cancer Study Group (2006). Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93. Journal of clinical oncology, 24(9), pp. 1332-41. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.03.0783

Basser, RL; O'Neill, A; Martinelli, G; Green, MD; Peccatori, F; Cinieri, S; Coates, AS; Gelber, RD; Aebi, S; Castiglione-Gertsch, M; Viale, G; Price, KN; Goldhirsch, A; International, Breast Cancer Study Group (2006). Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95. Journal of clinical oncology, 24(3), pp. 370-8. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.03.5196

Hathaway, LJ; Stutzmann Meier, P; Bättig, P; Aebi, S; Mühlemann, K (2004). A homologue of aliB is found in the capsule region of nonencapsulated Streptococcus pneumoniae. Journal of bacteriology, 186(12), pp. 3721-9. Washington, D.C.: American Society for Microbiology 10.1128/JB.186.12.3721-3729.2004

Conference or Workshop Item

Girardin, D; Ballabio, N; Imboden, S; Pfaltz, K; Tapia, C; Jaggi, R; Altermatt, HJ; Aebi, S; Mueller, MD; Günthert, A (2013). Diskrepanz der klinisch-pathologischen "intrinsischen" Subtypen (IHC-Klassifikation, St-Gallen Konzensus 2011) zwischen Primärtumore und Lokalrezidive verglichen mit Diskrepanz zwischen Primärtumore und asynchrone Zweittumore beim Mammakarzinom. In: Jahreskongress SGGG, Lugano 2013. Jahreskongress SGGG, Lugano 2013

This list was generated on Wed Aug 16 17:07:46 2017 CEST.
Provide Feedback